The authors reply
- PMID: 39637273
- DOI: 10.1097/CCM.0000000000006435
The authors reply
Conflict of interest statement
Dr. Koyner received funding from Novartis and Bioporto; their institution received funding from Biomerieux; and they received support for research from the National Institutes of Health (NIH), Fresenius, Baxter, Mallinckrodt, Alexion, Guard Therapeutics, Seastar, the American Society of Nephrology, the International Symposium on Intensive Care & Emergency Medicine, and the Central Society for Clinical and Translational Research. Dr. Ostermann received support for research from Baxter, Biomerieux, and La Jolla Pharma. Dr. Bhatraju’s institution received funding from the NIH. Dr. Birkelo has disclosed that she does not have any potential conflicts of interest.
References
-
- da Hora Passos R, da Cunha Lyrio RM, Zawadzki B: Precision medicine expedition: Tackling challenges in acute kidney injury. Crit Care Med. 2024; 52:e630–e631
-
- Birkelo BC, Koyner JL, Ostermann M, et al.: The road to precision medicine for acute kidney injury. Crit Care Med. 2024; 52:1127–1137
LinkOut - more resources
Full Text Sources
